Pyxis Oncology (PYXS)
Develops MICVO, an investigational ADC for difficult-to-treat solid tumors.
$3.73
Pre-market−0.01 (−0.27%)
At close$3.74(+8.72%)
Something off on this page? Send us feedback.
Next report
Nov 2, 2026
estimated · in 60 days
EPS estimate
−$0.27
Revenue estimate
—
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.32−$0.35−$0.30−$0.35−$0.29−$0.37−$0.40Pending
Estimate−$0.33−$0.29−$0.36−$0.36−$0.35−$0.35−$0.35−$0.27
Surprise+3.0%−20.7%+16.7%+2.8%+17.1%−5.7%−14.3%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$3.4M—$2.8M—$11.0M—$918.0KPending
Estimate————$125.0K$19.4K$33.3K—
Surprise————+8,730.4%—+2,654.0%—
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.27 | — | — |
| Aug 2026 | −$0.35 | −$0.40 | −14.3% |
| May 2026 | −$0.35 | −$0.37 | −5.7% |
| Mar 2026 | −$0.35 | −$0.29 | +17.1% |
| Nov 2025 | −$0.36 | −$0.35 | +2.8% |
The latest year is open to everyone — the 22 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Oct 2021 | |||
| Mar 2021 | |||
| Dec 2020 | |||
| Sep 2020 | |||
| Jun 2020 | |||
| Mar 2020 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Nov 2, 2026 | −$0.27 | — | — | — | — | — | — |
| Aug 13, 2026 | −$0.35 | −$0.40 | −14.3% | $33.3K | $918.0K | +2,654.0% | −5.4% |
| May 14, 2026 | −$0.35 | −$0.37 | −5.7% | $19.4K | — | — | +3.2% |
| Mar 23, 2026 | −$0.35 | −$0.29 | +17.1% | $125.0K | $11.0M | +8,730.4% | −4.2% |
| Nov 3, 2025 | −$0.36 | −$0.35 | +2.8% | — | — | — | +2.4% |
The latest year is open to everyone — the 22 quarters behind it read with an account. Sign in | |||||||
| Aug 14, 2025 | |||||||
| May 15, 2025 | |||||||
| Mar 18, 2025 | |||||||
| Nov 12, 2024 | |||||||
| Aug 14, 2024 | |||||||
| May 14, 2024 | |||||||
| Mar 21, 2024 | |||||||
| Nov 7, 2023 | |||||||
| Aug 11, 2023 | |||||||
| May 11, 2023 | |||||||
| Mar 22, 2023 | |||||||
| Nov 1, 2022 | |||||||
| Aug 15, 2022 | |||||||
| May 13, 2022 | |||||||
| Mar 29, 2022 | |||||||
| Nov 15, 2021 | |||||||
| Oct 8, 2021 | |||||||
| Mar 31, 2021 | |||||||
| Dec 31, 2020 | |||||||
| Sep 30, 2020 | |||||||
| Jun 30, 2020 | |||||||
| Mar 31, 2020 | |||||||